カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の持続型皮下インスリン注入装置市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Continuous Subcutaneous Insulin Infusion Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17377）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17377
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：92
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の持続型皮下インスリン注入装置市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

持続型皮下インスリン注入装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の持続型皮下インスリン注入装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

持続型皮下インスリン注入装置市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ノーマルポンプ、パッチポンプ

用途別セグメントは次のように区分されます。
・Ⅰ型糖尿病、Ⅱ型糖尿病

世界の持続型皮下インスリン注入装置市場の主要な市場プレーヤーは以下のとおりです。
・Medtronic、Roche、Insulet Corp、Tandem Diabetes care、Valeritas、SOOIL、Microport

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、持続型皮下インスリン注入装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な持続型皮下インスリン注入装置メーカーの企業概要、2019年～2022年までの持続型皮下インスリン注入装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な持続型皮下インスリン注入装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別持続型皮下インスリン注入装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの持続型皮下インスリン注入装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での持続型皮下インスリン注入装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および持続型皮下インスリン注入装置の産業チェーンを掲載しています。
・第13、14、15章では、持続型皮下インスリン注入装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 持続型皮下インスリン注入装置の概要
- 種類別分析（2017年vs2021年vs2028年）：ノーマルポンプ、パッチポンプ
- 用途別分析（2017年vs2021年vs2028年）：Ⅰ型糖尿病、Ⅱ型糖尿病
- 世界の持続型皮下インスリン注入装置市場規模・予測
- 世界の持続型皮下インスリン注入装置生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Medtronic、Roche、Insulet Corp、Tandem Diabetes care、Valeritas、SOOIL、Microport
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ノーマルポンプ、パッチポンプ
・用途別分析2017年-2028年：Ⅰ型糖尿病、Ⅱ型糖尿病
・持続型皮下インスリン注入装置の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・持続型皮下インスリン注入装置のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・持続型皮下インスリン注入装置のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・持続型皮下インスリン注入装置の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・持続型皮下インスリン注入装置の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Continuous Subcutaneous Insulin Infusion Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Continuous Subcutaneous Insulin Infusion Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Type I Diabetes accounting for % of the Continuous Subcutaneous Insulin Infusion Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Normal Pump segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Continuous Subcutaneous Insulin Infusion Devices include Medtronic, Roche, Insulet Corp, Tandem Diabetes care, and Valeritas, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Continuous Subcutaneous Insulin Infusion Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Normal Pump
Patch Pump
Market segment by Application can be divided into
Type I Diabetes
Type II Diabetes
The key market players for global Continuous Subcutaneous Insulin Infusion Devices market are listed below:
Medtronic
Roche
Insulet Corp
Tandem Diabetes care
Valeritas
SOOIL
Microport
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Continuous Subcutaneous Insulin Infusion Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Continuous Subcutaneous Insulin Infusion Devices, with price, sales, revenue and global market share of Continuous Subcutaneous Insulin Infusion Devices from 2019 to 2022.
Chapter 3, the Continuous Subcutaneous Insulin Infusion Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Continuous Subcutaneous Insulin Infusion Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Continuous Subcutaneous Insulin Infusion Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Continuous Subcutaneous Insulin Infusion Devices.
Chapter 13, 14, and 15, to describe Continuous Subcutaneous Insulin Infusion Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Continuous Subcutaneous Insulin Infusion Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Normal Pump
1.2.3 Patch Pump
1.3 Market Analysis by Application
1.3.1 Overview: Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Global Continuous Subcutaneous Insulin Infusion Devices Market Size & Forecast
1.4.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Continuous Subcutaneous Insulin Infusion Devices Sales in Volume (2017-2028)
1.4.3 Global Continuous Subcutaneous Insulin Infusion Devices Price (2017-2028)
1.5 Global Continuous Subcutaneous Insulin Infusion Devices Production Capacity Analysis
1.5.1 Global Continuous Subcutaneous Insulin Infusion Devices Total Production Capacity (2017-2028)
1.5.2 Global Continuous Subcutaneous Insulin Infusion Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Continuous Subcutaneous Insulin Infusion Devices Market Drivers
1.6.2 Continuous Subcutaneous Insulin Infusion Devices Market Restraints
1.6.3 Continuous Subcutaneous Insulin Infusion Devices Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Devices Product and Services
2.1.4 Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Continuous Subcutaneous Insulin Infusion Devices Product and Services
2.2.4 Roche Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Insulet Corp
2.3.1 Insulet Corp Details
2.3.2 Insulet Corp Major Business
2.3.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product and Services
2.3.4 Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Tandem Diabetes care
2.4.1 Tandem Diabetes care Details
2.4.2 Tandem Diabetes care Major Business
2.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product and Services
2.4.4 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Valeritas
2.5.1 Valeritas Details
2.5.2 Valeritas Major Business
2.5.3 Valeritas Continuous Subcutaneous Insulin Infusion Devices Product and Services
2.5.4 Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 SOOIL
2.6.1 SOOIL Details
2.6.2 SOOIL Major Business
2.6.3 SOOIL Continuous Subcutaneous Insulin Infusion Devices Product and Services
2.6.4 SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Microport
2.7.1 Microport Details
2.7.2 Microport Major Business
2.7.3 Microport Continuous Subcutaneous Insulin Infusion Devices Product and Services
2.7.4 Microport Continuous Subcutaneous Insulin Infusion Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Continuous Subcutaneous Insulin Infusion Devices Breakdown Data by Manufacturer
3.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Continuous Subcutaneous Insulin Infusion Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Continuous Subcutaneous Insulin Infusion Devices Manufacturer Market Share in 2021
3.4.2 Top 6 Continuous Subcutaneous Insulin Infusion Devices Manufacturer Market Share in 2021
3.5 Global Continuous Subcutaneous Insulin Infusion Devices Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Continuous Subcutaneous Insulin Infusion Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Continuous Subcutaneous Insulin Infusion Devices Market Size by Region
4.1.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales in Volume by Region (2017-2028)
4.1.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2017-2028)
4.2 North America Continuous Subcutaneous Insulin Infusion Devices Revenue (2017-2028)
4.3 Europe Continuous Subcutaneous Insulin Infusion Devices Revenue (2017-2028)
4.4 Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue (2017-2028)
4.5 South America Continuous Subcutaneous Insulin Infusion Devices Revenue (2017-2028)
4.6 Middle East and Africa Continuous Subcutaneous Insulin Infusion Devices Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales in Volume by Type (2017-2028)
5.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2017-2028)
5.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Continuous Subcutaneous Insulin Infusion Devices Sales in Volume by Application (2017-2028)
6.2 Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2017-2028)
6.3 Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2028)
7.2 North America Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2028)
7.3 North America Continuous Subcutaneous Insulin Infusion Devices Market Size by Country
7.3.1 North America Continuous Subcutaneous Insulin Infusion Devices Sales in Volume by Country (2017-2028)
7.3.2 North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2028)
8.2 Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2028)
8.3 Europe Continuous Subcutaneous Insulin Infusion Devices Market Size by Country
8.3.1 Europe Continuous Subcutaneous Insulin Infusion Devices Sales in Volume by Country (2017-2028)
8.3.2 Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2028)
9.2 Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2028)
9.3 Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Market Size by Region
9.3.1 Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2028)
10.2 South America Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2028)
10.3 South America Continuous Subcutaneous Insulin Infusion Devices Market Size by Country
10.3.1 South America Continuous Subcutaneous Insulin Infusion Devices Sales in Volume by Country (2017-2028)
10.3.2 South America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2028)
11.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2028)
11.3 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Market Size by Country
11.3.1 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Continuous Subcutaneous Insulin Infusion Devices and Key Manufacturers
12.2 Manufacturing Costs Percentage of Continuous Subcutaneous Insulin Infusion Devices
12.3 Continuous Subcutaneous Insulin Infusion Devices Production Process
12.4 Continuous Subcutaneous Insulin Infusion Devices Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Continuous Subcutaneous Insulin Infusion Devices Typical Distributors
13.3 Continuous Subcutaneous Insulin Infusion Devices Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 6. Medtronic Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Major Business
Table 9. Roche Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 10. Roche Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Insulet Corp Basic Information, Manufacturing Base and Competitors
Table 12. Insulet Corp Major Business
Table 13. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 14. Insulet Corp Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Tandem Diabetes care Basic Information, Manufacturing Base and Competitors
Table 16. Tandem Diabetes care Major Business
Table 17. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 18. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Valeritas Basic Information, Manufacturing Base and Competitors
Table 20. Valeritas Major Business
Table 21. Valeritas Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 22. Valeritas Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. SOOIL Basic Information, Manufacturing Base and Competitors
Table 24. SOOIL Major Business
Table 25. SOOIL Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 26. SOOIL Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Microport Basic Information, Manufacturing Base and Competitors
Table 28. Microport Major Business
Table 29. Microport Continuous Subcutaneous Insulin Infusion Devices Product and Services
Table 30. Microport Continuous Subcutaneous Insulin Infusion Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Continuous Subcutaneous Insulin Infusion Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Continuous Subcutaneous Insulin Infusion Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Continuous Subcutaneous Insulin Infusion Devices Production Site of Key Manufacturer
Table 36. Continuous Subcutaneous Insulin Infusion Devices New Entrant and Capacity Expansion Plans
Table 37. Continuous Subcutaneous Insulin Infusion Devices Mergers & Acquisitions in the Past Five Years
Table 38. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2017-2022) & (K Units)
Table 39. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2023-2028) & (K Units)
Table 40. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2022) & (K Units)
Table 43. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2023-2028) & (K Units)
Table 44. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2022) & (K Units)
Table 49. Global Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2023-2028) & (K Units)
Table 50. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Continuous Subcutaneous Insulin Infusion Devices Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2017-2022) & (K Units)
Table 55. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2023-2028) & (K Units)
Table 56. North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2022) & (K Units)
Table 59. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2023-2028) & (K Units)
Table 60. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2022) & (K Units)
Table 61. North America Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2023-2028) & (K Units)
Table 62. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2017-2022) & (K Units)
Table 63. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2023-2028) & (K Units)
Table 64. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2022) & (K Units)
Table 67. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2023-2028) & (K Units)
Table 68. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2022) & (K Units)
Table 69. Europe Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2023-2028) & (K Units)
Table 78. South America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2017-2022) & (K Units)
Table 79. South America Continuous Subcutaneous Insulin Infusion Devices Sales by Country (2023-2028) & (K Units)
Table 80. South America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Continuous Subcutaneous Insulin Infusion Devices Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2022) & (K Units)
Table 83. South America Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2023-2028) & (K Units)
Table 84. South America Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2022) & (K Units)
Table 85. South America Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales by Application (2023-2028) & (K Units)
Table 94. Continuous Subcutaneous Insulin Infusion Devices Raw Material
Table 95. Key Manufacturers of Continuous Subcutaneous Insulin Infusion Devices Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Continuous Subcutaneous Insulin Infusion Devices Typical Distributors
Table 99. Continuous Subcutaneous Insulin Infusion Devices Typical Customers
List of Figures
Figure 1. Continuous Subcutaneous Insulin Infusion Devices Picture
Figure 2. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type in 2021
Figure 3. Normal Pump
Figure 4. Patch Pump
Figure 5. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application in 2021
Figure 6. Type I Diabetes
Figure 7. Type II Diabetes
Figure 8. Global Continuous Subcutaneous Insulin Infusion Devices Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Continuous Subcutaneous Insulin Infusion Devices Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Continuous Subcutaneous Insulin Infusion Devices Sales (2017-2028) & (K Units)
Figure 11. Global Continuous Subcutaneous Insulin Infusion Devices Price (2017-2028) & (US$/Unit)
Figure 12. Global Continuous Subcutaneous Insulin Infusion Devices Production Capacity (2017-2028) & (K Units)
Figure 13. Global Continuous Subcutaneous Insulin Infusion Devices Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Continuous Subcutaneous Insulin Infusion Devices Market Drivers
Figure 15. Continuous Subcutaneous Insulin Infusion Devices Market Restraints
Figure 16. Continuous Subcutaneous Insulin Infusion Devices Market Trends
Figure 17. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Manufacturer in 2021
Figure 18. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Manufacturer in 2021
Figure 19. Continuous Subcutaneous Insulin Infusion Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Continuous Subcutaneous Insulin Infusion Devices Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Continuous Subcutaneous Insulin Infusion Devices Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2017-2028)
Figure 23. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2017-2028)
Figure 24. North America Continuous Subcutaneous Insulin Infusion Devices Revenue (2017-2028) & (USD Million)
Figure 25. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue (2017-2028) & (USD Million)
Figure 27. South America Continuous Subcutaneous Insulin Infusion Devices Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue (2017-2028) & (USD Million)
Figure 29. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2017-2028)
Figure 30. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Type (2017-2028)
Figure 31. Global Continuous Subcutaneous Insulin Infusion Devices Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2028)
Figure 33. Global Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Application (2017-2028)
Figure 34. Global Continuous Subcutaneous Insulin Infusion Devices Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2017-2028)
Figure 36. North America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2028)
Figure 37. North America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2017-2028)
Figure 38. North America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2017-2028)
Figure 39. United States Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2017-2028)
Figure 43. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2028)
Figure 44. Europe Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2017-2028)
Figure 45. Europe Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2017-2028)
Figure 46. Germany Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2017-2028)
Figure 55. China Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2017-2028)
Figure 62. South America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2028)
Figure 63. South America Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Country (2017-2028)
Figure 64. South America Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Continuous Subcutaneous Insulin Infusion Devices Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Continuous Subcutaneous Insulin Infusion Devices Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Continuous Subcutaneous Insulin Infusion Devices in 2021
Figure 76. Manufacturing Process Analysis of Continuous Subcutaneous Insulin Infusion Devices
Figure 77. Continuous Subcutaneous Insulin Infusion Devices Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 医療用インスリン注入ポンプのグローバル市場展望 2023年-2029年：クローズドループ、オープンループ
  • 世界のインスリン貯蔵装置市場2022年：市場規模予測（～2028年）
  • 世界のインスリン薬物送達デバイス市場2022年：市場規模予測（～2028年）
  • 世界の圧力輸液装置市場2022年：市場規模予測（～2028年）
  • 世界の皮下型避妊インプラント市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17377 )"世界の持続型皮下インスリン注入装置市場2022年：市場規模予測（～2028年）" (英文：Global Continuous Subcutaneous Insulin Infusion Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。